T2 Biosystems Reports Granting of Inducement Awards
Apr 04, 2018 20:05 pm UTC| Business
LEXINGTON, Mass., April 04, 2018 -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare,...
CRISPR Therapeutics Announces the Appointment of Steve Caffé as Head of Regulatory Affairs
Apr 04, 2018 20:01 pm UTC| Business
ZUG, Switzerland and CAMBRIDGE, MA., April 04, 2018 -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced the...
Apricus Biosciences Announces Closing of $3.55 Million Public Offering
Apr 04, 2018 20:01 pm UTC| Business
SAN DIEGO, April 04, 2018 -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the closing of its previously announced...
Apr 04, 2018 20:01 pm UTC| Business
-- PDUFA Action Date in October 2018 -- BOSTON, April 04, 2018 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Applications...
Collegium to Present at the H.C. Wainwright Global Life Sciences Conference
Apr 04, 2018 20:01 pm UTC| Business
CANTON, Mass., April 04, 2018 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that management will present at the H.C. Wainwright Global Life Sciences Conference on Tuesday, April 10, 2018 at 11:55 a.m....
Old National to announce first-quarter 2018 earnings and hold conference call / webcast
Apr 04, 2018 20:00 pm UTC| Business
EVANSVILLE, Ind., April 04, 2018 -- Old National Bancorp (NASDAQ:ONB) will release details of its financial results for the first quarter of 2018 on Monday, April 23, 2018, prior to the market opening. A conference...
Apr 04, 2018 20:00 pm UTC| Business
NEW YORK, April 04, 2018 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Henry Schein, Inc. ("Henry Schein")...